Τρίτη 24 Απριλίου 2018

ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration

Ataxia Telangiectasia and Rad3 related protein (ATR) is a central mediator of the response to DNA damage that may cause the quiescent resistance of cancer initiating cells to genotoxic radiotherapy. NVP-BEZ235...

https://ift.tt/2r0hhge

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου